✦ LIBER ✦

O28. Randomized phase II study of concomitant chemoradiation using weekly carboplatin/paclitaxel/concomitant boost radiation with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced head and neck cancer

✍ Scribed by Haddad, R.; Braschayko, P.; Sonis, S.; Posner, M.; Wirth, L.; Tishler, R.

Book ID: 119336524
Publisher: Elsevier Science
Year: 2009
Weight: 39 KB
Volume: 3
Category: Article
ISSN: 1744-7895
DOI: 10.1016/j.oos.2009.06.113

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II randomized study of concomitant

Phase II randomized study of concomitant chemoradiation using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neck

✍ Robert Haddad; Lori Wirth; Rosemary Costello; Linda Weeks; Marshall Posner 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Randomized phase 2 study of concomitant

Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer

✍ Robert Haddad; Stephen Sonis; Marshall Posner; Lori Wirth; Rosemary Costello; Pa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB 👁 1 views

## Abstract ## BACKGROUND: A randomized phase 2 study was performed to investigate the efficacy/toxicity of combining concomitant boost radiation and weekly carboplatin/paclitaxel with or without amifostine in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). ##